Latest Share Chat

REMOVE ADS

Hemogenyx Pharmaceuticals Share News (HEMO)

Hemogenyx Pharmaceuticals Information

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes

Get Live Data

794.00 -35.50 (-4.44%)

Bid:

735.00

Ask:

794.00

Spread: 59.00 (8.027%)

Market Cap: £53.99m

Last checked at -

Intraday Hemogenyx Pharmaceuticals Share Chart

REMOVE ADS

Hemogenyx Pharmaceuticals News

UK shareholder meetings calendar - next 7 days

IN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia treatment

Hemogenyx Pharmaceuticals PLC - biopharmaceutical company focused on treatments for blood diseases - Updates on its ongoing activities and progress. S...

EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Hemogenyx Pharmaceuticals raises money for leukaemia treatment

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it has raised GBP3.3 million through a placing.

Hemogenyx shares rise on potential for CBR to treat brain diseases

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said research has shown that its proprietary chimeric bait receptor can be delivered into th...

Hemogenyx says CBR can be used intranasally to treat viral infections

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said its chimeric bait receptor can be delivered intranasally in the form of messenger RN...

IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - US Food & Drug Administration...

IN BRIEF: Hemogenyx hails US patent application progress

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - Celebrates as patent applicat...